The cancer diagnostics company has gone into a trading halt following an adverse decision on reimbursement of its US bladder tests.
The investment comes ahead of a planned $10m-$15m capital raise to help reduce debt.
Being AI’s share price has fallen on the news, while Solution Dynamics has gone into a trading halt.
The future is still uncertain for the company despite winning a A$43m judgement against a high roller and selling a property for A$67m.
CEO Todd Hunter says investing in them is easy; getting a good return is harder.
However, the retailer’s managing director is confident in the group’s ability to deliver a strong result in the circumstances.
Gentailer sees significant upside from Manawa acquisition when its supply contract with Mercury resets to market price.
Roche was not named in the Asic legal claim, but has faced strong pressure from investors to resign.
The breach follows weaker quarterly trading with revenue down against budget.
Cash and scrip deal at 48% premium is supported by Manawa shareholder Infratil.